Depending on the cell line and the phase of the cell cycle at the time of treatment, cells that may have already passed G1/S checkpoint or the intra-S-checkpoints were arrested at the G2/M checkpoint by differential reduction of CDC2 expression as shown in NCCIT cells and primary GBM. The gene discussed is CDK1; the disease is glioblastoma.